


Ask a doctor about a prescription for Psotriol
Calcipotriol+ Betamethasone
Psotriol ointment is used on the skin to treat psoriasis in adults. Psoriasis is caused by the skin cells being produced too quickly. This leads to redness, scaling, and thickening of the skin. Psotriol ointment contains calcipotriol and betamethasone. Calcipotriol helps to slow down the growth of skin cells to normal values, while betamethasone reduces inflammation.
Since Psotriol contains a strong steroid, it should NOT be used in the course of skin diseases such as:
Before starting to use Psotriol, the patient should discuss it with their doctor or pharmacist if:
Special precautions: The patient should avoid using the medicine on more than 30% of the body surface or using more than 15g of the medicine per day. The patient should avoid using the medicine under bandages or dressings, as this increases the absorption of steroids. The patient should avoid using the medicine on large areas of damaged skin, mucous membranes, or skin folds (groin, armpits, under the breasts), as this increases the absorption of steroids. The patient should avoid using the medicine on the face or genital areas, as they are very sensitive to the effects of steroids. The patient should avoid excessive sunbathing, excessive use of sunbeds, and other forms of light therapy. The patient should contact their doctor if they experience blurred vision or other vision disturbances.
Psotriol is not recommended for use in children under 18 years of age.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take, including those available without a prescription.
Psotriol should not be used if the patient is pregnant (or thinks they may be pregnant) or breastfeeding, unless agreed with the doctor. If the doctor has agreed to breastfeeding during treatment, the patient should be cautious and not use Psotriol on the breast area. Before using any medicine, the patient should consult their doctor or pharmacist.
This medicine should not affect the patient's ability to drive or use machines.
Butylhydroxytoluene (E 321) may cause local skin reactions (e.g., contact dermatitis) or eye and mucous membrane irritation.
This medicine should always be used as directed by the doctor. In case of doubts, the patient should consult their doctor or pharmacist. The way to use Psotriol: apply to the skin. Instructions for proper use:
Duration of treatment
In case of using other medicines containing calcipotriol, the total amount of calcipotriol-containing medicines should not exceed 15 grams per day, and the treated skin area should not exceed 30% of the total body surface.
Most patients observe obvious treatment results after 2 weeks, even if the symptoms of psoriasis have not yet disappeared in the treated area.
A patient who has used more than 15 grams of ointment in a day should contact their doctor. Excessive use of Psotriol may cause disturbances in calcium levels in the blood, which usually return to normal after discontinuation of treatment. The doctor may recommend a blood test to check if the use of too much ointment has caused a disturbance in calcium levels in the blood. Prolonged, excessive use of the medicine may also suppress the normal functioning of the adrenal glands (located near the kidneys and producing hormones).
Do not use a double dose to make up for a missed dose.
The use of Psotriol should be stopped according to the doctor's instructions. It may be necessary to gradually stop using the medicine, especially if it has been used for a long time. In case of any further doubts related to the use of the medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Psotriol can cause side effects, although not everybody gets them. Severe side effects: If any of the following symptoms occur, the patient should inform their doctor or nurse immediately or as soon as possible. It may be necessary to stop the treatment. There have been reports of the following severe side effects of Psotriol: Not very common (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1000 people)
It is known that some severe side effects are caused by betamethasone (a strong steroid), one of the ingredients of Psotriol. If any of the following severe side effects occur, the patient should inform their doctor as soon as possible. They are likely to occur after prolonged use, use in skin folds (e.g., in the groin, under the arms, or under the breasts), under occlusive dressings, or on large areas of skin. These side effects include:
Severe side effects caused by calcipotriol.
Less severe side effects: The following less severe side effects of Psotriol have been reported. Common side effects (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1000 people)
Less severe side effects caused by betamethasone, especially when used for a long time, are listed below. If any of these occur, the patient should inform their doctor or nurse as soon as possible.
Less severe side effects caused by calcipotriol include
If the patient experiences any side effects, including any side effects not listed in this leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Post-Marketing Surveillance of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, e-mail: [email protected]. Side effects can also be reported to the marketing authorization holder. By reporting side effects, more information can be gathered on the safety of the medicine.
This medicine should be stored out of sight and reach of children. Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date refers to the last day of that month. Do not store above 25°C. Do not store in the refrigerator. Shelf life after first opening the tube: 1 year. The patient should write the date of first opening the tube in the space provided on the carton. Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substances of Psotriol are: calcipotriol and betamethasone. One gram of ointment contains 50 micrograms of calcipotriol (as calcipotriol monohydrate) and 0.5 mg of betamethasone (as betamethasone dipropionate). The other ingredients are: liquid paraffin, polyoxypropylene stearyl ether [contains butylhydroxytoluene (E 321)], white petrolatum (containing all-rac-α-tocopherol)
Psotriol is a nearly white to yellow ointment, in an aluminum tube with an inner epoxy coating and a PE cap, in a cardboard box. Pack sizes: 30 g, 60 g. Not all pack sizes may be marketed.
SUN-FARM Sp. z o.o., ul. Dolna 21, 05-092 Łomianki
mibe GmbH Arzneimittel, Münchener Straße 15, 06796 Brehna, Germany; SUN-FARM Sp. z o.o., ul. Dolna 21, 05-092 Łomianki, Poland
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Psotriol – subject to medical assessment and local rules.